chiral-quest/apis.yml at main · api-evangelist/chiral-quest · GitHub

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
aid: chiral-quest
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/chiral-quest.png
name: Chiral Quest
description: 'Chiral Quest (Suzhou) Co., Ltd. (凯瑞斯德生化（苏州）有限公司) is a Chinese pharmaceutical
  CDMO specializing in chiral chemistry. The company operates asymmetric catalytic hydrogenation,
  enzyme-catalyzed biosynthesis, flow chemistry, and process innovation technology platforms, using
  proprietary catalysts to develop and manufacture chiral drug molecules, key raw materials, regulatory
  starting materials (RSMs), and advanced GMP intermediates for global pharmaceutical companies. Founded
  around its asymmetric hydrogenation catalyst technology, Chiral Quest merged with Jiangxi Longlai in
  2012 and with Suzhou Pengxu in 2020; the group employs more than 800 people including a research team
  of roughly 150. Suzhou is the parent company and R&D center, Jiangxi Longlai is the manufacturing base,
  and the company maintains offices in the United Kingdom and the United States. Chiral Quest is a
  brochure-site company with no public API, developer portal, or machine-readable data surface.'
url: https://raw.githubusercontent.com/api-evangelist/chiral-quest/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- idg-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Healthcare
- Pharmaceuticals
- Chemistry
- Chiral Chemistry
- Drug Discovery
- CDMO
- Contract Manufacturing
- Fine Chemicals
- Asymmetric Catalysis
- Biocatalysis
- Flow Chemistry
- Active Pharmaceutical Ingredients
- China
apis: []
common:
- type: Website
  url: http://www.chiralquest.com/en/
- type: About
  url: http://www.chiralquest.com/en/company-profile.html
- type: Contact
  url: http://www.chiralquest.com/en/contact-information.html
- type: News
  url: http://www.chiralquest.com/en/news-consultation.html
- type: Careers
  url: http://www.chiralquest.com/join-us.html
- type: Services
  url: http://www.chiralquest.com/en/customized-development-production.html
- type: Database
  url: http://www.chiralquest.com/en/amino-acid-database.html
- type: DomainSecurity
  url: security/chiral-quest-domain-security.yml
- type: LLMsTxt
  url: llms/chiral-quest-llms.txt
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 3
  pass: local-v1
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io